title: Intermittent haemodialysis and continuous veno-venous dialysis are effective in mitigating major bleeding due to dabigatran.
authors.affiliation: Department of Haematology, Liverpool Hospital, Sydney South West Pathology Service (SSWPS), Liverpool, NSW, Australia. b.getta@gmail.com.
authors.forename: Bartlomiej
authors.initials: B
authors.lastname: Getta
authors.forename: Niccolo
authors.initials: N
authors.lastname: Muller
authors.forename: Penelope
authors.initials: P
authors.lastname: Motum
authors.forename: Danny
authors.initials: D
authors.lastname: Hsu
authors.forename: Diane
authors.initials: D
authors.lastname: Zebeljan
authors.forename: David
authors.initials: D
authors.lastname: Rosenfeld
mesh_terms: D000369:Aged, 80 and over; D000991:Antithrombins / Q000008:administration & dosage / Q000009:adverse effects*; D001562:Benzimidazoles / Q000008:administration & dosage / Q000009:adverse effects*; D000069604:Dabigatran; D006470:Hemorrhage / Q000139:chemically induced* / Q000628:therapy*; D006801:Humans; D008297:Male; D006435:Renal Dialysis; D015091:beta-Alanine / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives*
chemical_list: D000991:Antithrombins; D001562:Benzimidazoles; D015091:beta-Alanine; D000069604:Dabigatran
keywords: anticoagulants; anticoagulation; bleeding disorders